Beyond the cell lines, we have identified cytoplasmic EZH2 and complex formation between EZH2 and DLC1 in other lung cancer models, including NSCLC patient-derived xenografts and a mutant KRas mouse lung tumor model30. This evidence concerns the gene EZH2 and lung carcinoma.